TY - JOUR
T1 - The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance
T2 - An AMR Insights global perspective
AU - Ansari, Shamshul
AU - Hays, John P
AU - Global AMR Insights Ambassador Network
AU - Kemp, Andrew
AU - Okechukwu, Raymond
AU - Murugaiyan, Jayaseelan
AU - Ekwanzala, Mutshiene Deogratias
AU - Ruiz Alvarez, Maria Josefina
AU - Paul-Satyaseela, Maneesh
AU - Iwu, Chidozie Declan
AU - Balleste-Delpierre, Clara
AU - Septimus, Ed
AU - Mugisha, Lawrence
AU - Fadare, Joseph
AU - Chaudhuri, Susmita
AU - Chibabhai, Vindana
AU - Wadanamby, J M Rohini W W
AU - Daoud, Ziad
AU - Xiao, Yonghong
AU - Parkunan, Thulasiraman
AU - Khalaf, Yara
AU - M'Ikanatha, Nkuchia M
AU - van Dongen, Maarten B M
N1 - Funding: This study was supported by internal funding.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
PY - 2021/6
Y1 - 2021/6
N2 - The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic's effect on global AMR.
AB - The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic's effect on global AMR.
UR - http://www.scopus.com/inward/record.url?scp=85114822348&partnerID=8YFLogxK
U2 - 10.1093/jacamr/dlab038
DO - 10.1093/jacamr/dlab038
M3 - Article
C2 - 34192258
SN - 2632-1823
VL - 3
JO - JAC-Antimicrobial Resistance
JF - JAC-Antimicrobial Resistance
IS - 2
M1 - dlab038
ER -
